RenalGuard® is designed to reduce the toxic effects that contrast media can have on the kidneys, which may lead to a reduction in the incidence of Contrast-Induced Nephropathy (CIN) in at-risk patients.
The following papers and abstracts discuss the use of RenalGuard Therapy® in the prevention of Contrast-Induced Kidney Injury (CIN).
Author
Barbanti, Marco
Title
Optimisation and simplification of transcatheter aortic valve implantation therapy
Source
Expert Review of Cardiovascular Therapy
Luckraz, Heyman
The use of the RenalGuard system in cardiac surgery with cardiopulmonary bypass: a first in man prospective, observational, feasibility pilot study
openheart
Prasad, Anand
Use of the RenalGuard system to prevent contrast-induced AKI: A meta-analysis
Journal of Interventional Cardiology
Bartorelli, Antonio L ; Marenzi, Giancarlo
High Urine Output With Matched Hydration for CI-AKI Prevention “Salus Per Aquam” (Health Through Water)
JACC: Cardiovascular Interventions
Putzu et al.
Prevention of Contrast-Induced Acute Kidney Injury by Furosemide With Matched Hydration in Patients Undergoing Interventional Procedures
JACC: Cardiovascular Interventions
Banai, Shmuel
Prevention of post procedural acute kidney injury in the catheterization laboratory in a real-world population
International Journal of Cardiology
Visconti, Gabriella
RenalGuard System for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation
EuroIntervention
Briguori, Carlo
RenalGuard system in high-risk patients for contrast-induced Acute Kidney Injury
American Heart Journal
Barbanti et al.
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement
JACC: Cardiovascular Interventions
T. Usmiani
AKIGUARD (acute kidney injury guarding device) independent, randomized and controlled trial on contrast-induced acute kidney injury prevention in the cath lab: in-hospital and one year outcomes
European Heart Journal ( 2014 )
Marenzi, Giancarlo, Bartorelli, Antonio, et al.
Prevention of Contrast Nephropathy by Furosemide with Matched Hydration: The MYTHOS Trial
JACC: Cardiovascular Interventions
Halpert, Andrew
RenalGuard – an old idea with a modern twist: preventing contrast-induced nephropathy through induced diuresis with matched replacement
EuroPCR 2012
Bertelli, Luca, et al.
Comparison Of Renalguard System, Continuous Venovenous Hemofiltration And Hydration In High-Risk Patients For Contrast-Induced Nephropathy
Journal of the American College of Cardiology
Briguori, Carlo, et al.
Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II)
Circulation
Dorval, Jean-Frarncois, et al.
Feasibility study of the RenalGuard™ balanced hydration system: A novel strategy for the prevention of contrast-induced nephropathy in high risk patients
International Journal of Cardiology